Stanford Think Tank on Diversity & Health Equity in Clinical Trials Module

Monday, January 29, 2024, 12:00 AM - Thursday, January 28, 2027, 11:59 PM, On Demand

The on-demand version of the Stanford Think Tank on Diversity & Health Equity in Clinical Trials is designed to document and extend the conversations initiated during our live event. This educational product serves as a continuation of our mission to address the underrepresentation of diverse participant populations in clinical trials and promote health equity. By curating content from the Morning Plenary, Panels, and Work Groups Report Out, we offer viewers an opportunity to engage with insightful discussions, innovative recommendations, and practical solutions. Our goal is to provide accessible knowledge that contributes to improving healthcare outcomes for all. Our target audience for this on-demand resource is diverse and inclusive, encompassing healthcare professionals, researchers, industry experts, community leaders, policymakers, and anyone interested in advancing diversity in clinical trials and fostering health equity. We believe that a broad audience is crucial in driving positive change in this critical area of healthcare. The on-demand content is presented in a format that includes the Morning Plenary, which comprises keynote sessions and presentations from esteemed thought leaders. Additionally, the panels feature expert discussions on the challenges and opportunities in promoting diversity and health equity within clinical trials. Lastly, the Work Groups Report Outs provide valuable insights and recommendations gleaned from specific workgroup sessions. Optional reflection questions are included.

  Release Date: January 29, 2024
  Expiration Date: January 28, 2027
  Estimated Time to Complete: 4.25 hours
  Registration Fee: FREE

Click Begin (at the top) to launch the activity.

AMA PRA Category 1 Credits™ (4.25 hours), Non-Physician Participation Credit (4.25 hours)

1. Describe the needs and identify the barriers to recruiting participants from underrepresented groups in clinical trials.
2. Implement effective and innovative recommendations for improving the enrollment of participants from underrepresented groups in clinical trials.
3. Determine how we define diversity for the future of clinical trials, including people with disabilities.
4. Discuss the significance of diversity in clinical trials and its direct impact on healthcare outcomes.

Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Activity for a maximum of 4.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
View references.

For activity related questions, please contact
     Name: Latha Palaniappan, MD, MS
     Title: Professor of Medicine (Cardiovascular Medicine) and, By Courtesy, of Epidemiology and Population Health
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education. 

The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. Hence, there are no relevant financial relationships with an ACCME-defined ineligible company for anyone who was in control of the content of this activity. 

Special Thank You to our sponsor Pharmaceutical Product Development